Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+432.1%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+432.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
150.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$7.34M+454.5%
2024$1.32M-72.3%
2023$4.77M+9696.4%
2022$48730.00-11.4%
2021$55000.00-